Filing Details
- Accession Number:
- 0001562180-19-000862
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-08 18:36:01
- Reporting Period:
- 2019-02-06
- Accepted Time:
- 2019-02-08 18:36:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100412 | Array Biopharma Inc | ARRY | Pharmaceutical Preparations (2834) | 841460811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1590157 | R Andrew Robbins | C/O Array Biopharma Inc. 3200 Walnut St Boulder CO 80301 | Coo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-06 | 37,500 | $8.20 | 212,120 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-02-06 | 87,500 | $4.63 | 299,620 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-06 | 239,626 | $20.03 | 59,994 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-02-06 | 37,500 | $0.00 | 37,500 | $8.20 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-02-06 | 87,500 | $0.00 | 87,500 | $4.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,500 | 2025-03-02 | No | 4 | M | Direct | |
| 0 | 2024-04-01 | No | 4 | M | Direct |
Footnotes
- The price reported for these shares is the weighted average sale price of transactions made at prices from $20.00 to $20.20. Details of actual prices for shares sold are available from the Issuer upon request.
- The option vests in four equal annual installments beginning on March 2, 2016.
- The option vests in four equal annual installments beginning on April 1, 2015.
Billionaire Hedge Funds
